AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29757876 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-agent carboplatin
Number of subjects: 146
Study 29757876 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin with gemcitabine
Number of subjects: 146
Study 29757876 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin with paclitaxel
Number of subjects: 146
Study 29757876 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin
Number of subjects: 146
Study 28028918 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed outreach intervention promoting cholesterol testing and facilitated test ordering (without requiring an office visit)
Number of subjects: 480
Study 28028918 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 480
Study 26580802 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS Assessments + Feedback (SA+F)
Number of subjects: 765
Study 26580802 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS Assessments (SA)
Number of subjects: 765
Study 26580802 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 765
Study 22954201 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan/amlodipine (5/20 mg)
Number of subjects: 276
Study 22954201 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan (20 mg)
Number of subjects: 276
Study 22954201 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (10 mg)
Number of subjects: 276
Study 21680153 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 400mg once-daily
Number of subjects: 51
Study 21680153 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 800mg once-daily
Number of subjects: 51
Study 21680153 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 1200mg once-daily
Number of subjects: 51
Study 18922236 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug
Number of subjects: 0
Study 18922236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16782489 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced feedback of practice requesting rates for nine laboratory tests
Number of subjects: 370
Study 16782489 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief educational reminder messages added to test result reports for nine laboratory tests
Number of subjects: 370
Study 16782489 — intervention group
Group type: EXPERIMENTAL
Intervention: Both enhanced feedback and reminder messages
Number of subjects: 370
Study 16782489 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 370
Study 12670616 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT)
Number of subjects: 172
Study 12670616 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 172
Study 10887926 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 10%
Number of subjects: 100
Study 10887926 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 10% + Flurbiprofen
Number of subjects: 100
Study 10887926 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 2.5%
Number of subjects: 100
Study 10887926 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 2.5% + Flurbiprofen
Number of subjects: 100
Study 8692536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus D-Trp-6-LHRH (decapeptyl)
Number of subjects: 34
Study 8692536 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 34
Study 1306775 — intervention group
Group type: EXPERIMENTAL
Intervention: Many punctures of low quantity sclerosant
Number of subjects: 60
Study 1306775 — intervention group
Group type: EXPERIMENTAL
Intervention: One puncture of large quantity sclerosant
Number of subjects: 60
Study 1306775 — intervention group
Group type: EXPERIMENTAL
Intervention: One puncture of large quantity sclerosant with transendoscopic balloon
Number of subjects: 60
Study 30064408 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy plus conventional treatment
Number of subjects: 134
Study 30064408 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 134
Study 26723196 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg daily until delivery
Number of subjects: 20
Study 26723196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 24228683 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive WASH improvements in water-scarce schools
Number of subjects: 185
Study 24228683 — intervention group
Group type: COMPARATOR
Intervention: School hygiene promotion and water treatment interventions and school sanitation improvements in schools with greater water availability
Number of subjects: 185
Study 23649064 — intervention group
Group type: EXPERIMENTAL
Intervention: Gates‐Glidden drills with apical stop prepared with #25 Flexofile files
Number of subjects: 50
Study 23649064 — intervention group
Group type: EXPERIMENTAL
Intervention: Gates‐Glidden drills with apical stop prepared with #30 Flexofile files
Number of subjects: 50
Study 23649064 — intervention group
Group type: EXPERIMENTAL
Intervention: Gates‐Glidden drills with apical stop prepared with #35 Flexofile files
Number of subjects: 50
Study 23649064 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper rotary instruments with apical stop prepared with F1
Number of subjects: 50
Study 23649064 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper rotary instruments with apical stop prepared with F2
Number of subjects: 50
Study 23649064 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 50
Study 21190603 — intervention group
Group type: EXPERIMENTAL
Intervention: Total saponins of Panax notoginseng (PNS) extract Xueshuantong 0.45 g once a day for 2 months
Number of subjects: 60
Study 21190603 — intervention group
Group type: COMPARATOR
Intervention: Bailing capsule of 1.0 g three times a day for 2 months
Number of subjects: 60
Study 18179528 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous smoking history
Number of subjects: 88
Study 18179528 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking intensity-duration
Number of subjects: 88
Study 16823067 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (150 microg subcutaneously once daily for 14 days after the second week of radiotherapy)
Number of subjects: 29
Study 16823067 — intervention group
Group type: COMPARATOR
Intervention: No GM-CSF (control group)
Number of subjects: 29
Study 12959731 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 0
Study 12959731 — intervention group
Group type: COMPARATOR
Intervention: Stenting with predilatation
Number of subjects: 0
Study 10624980 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape-recorded hypnosis instructions (Group E)
Number of subjects: 60
Study 10624980 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 60
Study 8923073 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% human albumin (HA trauma, n = 14; HA sepsis, n = 14)
Number of subjects: 56
Study 8923073 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% low‐molecular‐weight HES solution (HES trauma, n = 14; HES sepsis; n = 14)
Number of subjects: 56
Study 8923073 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 56
Study 1558306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg) + Dextroamphetamine (0.09 mg/kg)
Number of subjects: 12
Study 1558306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg) + Dextroamphetamine (0.18 mg/kg)
Number of subjects: 12
Study 1558306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg) + Placebo Dextroamphetamine
Number of subjects: 12
Study 1558306 — intervention group
Group type: COMPARATOR
Intervention: Placebo Ethanol + Dextroamphetamine (0.09 mg/kg)
Number of subjects: 12
Study 1558306 — intervention group
Group type: COMPARATOR
Intervention: Placebo Ethanol + Dextroamphetamine (0.18 mg/kg)
Number of subjects: 12
Study 1558306 — intervention group
Group type: COMPARATOR
Intervention: Placebo Ethanol + Placebo Dextroamphetamine
Number of subjects: 12
Study 1558306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol + Placebo Dextroamphetamine
Number of subjects: 12
Study 1558306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol + Dextroamphetamine (low-dose)
Number of subjects: 12
Study 1558306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol + Dextroamphetamine (high-dose)
Number of subjects: 12
Study 2936354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (10 mg, 2 times daily)
Number of subjects: 36
Study 2936354 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg, once daily)
Number of subjects: 36
Study 2936354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 30592344 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol TIVA
Number of subjects: 96
Study 30592344 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (SEVO) inhalational anaesthesia
Number of subjects: 96
Study 29521485 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-stimulation device (Veinoplus®)
Number of subjects: 38
Study 29521485 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable compression Velcro® wrap (Circaid Juxtafit®)
Number of subjects: 38
Study 29521485 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stretch bandage (Rosidal K®)
Number of subjects: 38
Study 26466812 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative demonstration using a technique similar to 'The Newlywed Game'
Number of subjects: 100
Study 25281044 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based algorithm (CBA) with blood glucose measurement every 30 minutes
Number of subjects: 75
Study 25281044 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based algorithm (CBA) with blood glucose measurement every 15 minutes
Number of subjects: 75
Study 25281044 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy using a fixed insulin dosing scheme
Number of subjects: 75
Study 22721929 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA chelation therapy for 3 months followed by as needed for 24 months
Number of subjects: 50
Study 22721929 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months followed by weekly for 5 weeks at 6-month intervals for 24 months
Number of subjects: 50
Study 22721929 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA chelation therapy
Number of subjects: 50
Study 22721929 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 22721929 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 50
Study 19966535 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group using standard mnemonics with instructions for two transfer tasks (text learning, name-face learning, grocery list learning, place learning)
Number of subjects: 0
Study 19966535 — intervention group
Group type: COMPARATOR
Intervention: Training group practicing strategies with two trained tasks without instructions
Number of subjects: 0
Study 19966535 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group practicing strategies with two trained tasks with instructions on all transfer tasks
Number of subjects: 0
Study 18283621 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic guide wire (HGW)
Number of subjects: 332
Study 18283621 — intervention group
Group type: COMPARATOR
Intervention: Standard ERCP catheter
Number of subjects: 332
Study 16340453 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.50 g ethanol/kg) drink
Number of subjects: 4
Study 16340453 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 4
Study 16340453 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress task
Number of subjects: 4
Study 16340453 — intervention group
Group type: COMPARATOR
Intervention: No intervention (basal levels)
Number of subjects: 4
Study 12461392 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2/TSRH
Number of subjects: 25
Study 12461392 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2 only
Number of subjects: 25
Study 12461392 — intervention group
Group type: COMPARATOR
Intervention: autograft/TSRH
Number of subjects: 25
Study 12461392 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 Pain Index and PCS subscales
Number of subjects: 25
Study 10525140 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFA) - 600 mg per day for 42 days
Number of subjects: 20
Study 10525140 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (placebo) - 600 mg per day for 42 days
Number of subjects: 20
Study 7725888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms kg‐1
Number of subjects: 60
Study 7725888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1 microgram kg‐1
Number of subjects: 60
Study 7725888 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study 1646291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 6 mg
Number of subjects: 519
Study 1646291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 8 mg
Number of subjects: 519
Study 1646291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 519
Study 7195156 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 micrograms terbutaline
Number of subjects: 0
Study 7195156 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms mepyramine
Number of subjects: 0
Study 7195156 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms betamethasone
Number of subjects: 0
Study 7195156 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline and mepyramine
Number of subjects: 0
Study 31452417 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam plus fentanyl (0.05 mg/kg midazolam + 1.5 μg/kg fentanyl)
Number of subjects: 80
Study 31452417 — intervention group
Group type: COMPARATOR
Intervention: Midazolam plus normal saline (0.05 mg/kg midazolam + 0.03 mL/kg normal saline)
Number of subjects: 80
Study 31452417 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam plus fentanyl
Number of subjects: 80
Study 27736246 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 mg/d green tea extract (GTE)
Number of subjects: 54
Study 27736246 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 mg/d sour tea extract (STE)
Number of subjects: 54
Study 27736246 — intervention group
Group type: COMPARATOR
Intervention: 450 mg/d maltodextrin (control)
Number of subjects: 54
Study 25950231 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% PVP-iodine rinse
Number of subjects: 38
Study 25950231 — intervention group
Group type: COMPARATOR
Intervention: Water rinse (Control)
Number of subjects: 38
Study 23982033 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers or renin-angiotensin-aldosterone system blockers
Number of subjects: 240
Study 23982033 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers
Number of subjects: 240
Study 23982033 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
Number of subjects: 240
Study 21674183 — intervention group
Group type: EXPERIMENTAL
Intervention: Quad-helix treatment
Number of subjects: 100
Study 21674183 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 100
Study 19953024 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/Formoterol (400/12 microg, 2 inhalations bid)
Number of subjects: 0
Study 19953024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17552955 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid 4 mg intravenously every 3 months for four treatments
Number of subjects: 42
Study 17552955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 17552955 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 42
Study 16283191 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Lavasept
Number of subjects: 67
Study 16283191 — intervention group
Group type: COMPARATOR
Intervention: 1.25% PVP-iodine
Number of subjects: 67
Study 16283191 — intervention group
Group type: COMPARATOR
Intervention: Ringer's solution
Number of subjects: 67
Study 11901246 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 0
Study 11901246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10217590 — intervention group
Group type: EXPERIMENTAL
Intervention: Avaxim vaccine (inactivated hepatitis A vaccine), administered in two doses six months apart.
Number of subjects: 189
Study 7775263 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT‐11 at 80 or 90 mg/m2 plus cisplatin at 60 mg/m2
Number of subjects: 23
Study 7775263 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT‐11 at 80 or 90 mg/m2 plus cisplatin at 80 mg/m2 with granulocyte colony-stimulating factor support (2 micrograms/kg x 16 days)
Number of subjects: 23
Study 7775263 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT‐11
Number of subjects: 23
Study 2184649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg
Number of subjects: 14
Study 2184649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg
Number of subjects: 14
Study 2184649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 14
Study 2184649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg, 20 mg, 30 mg
Number of subjects: 14
Study 2184649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 6103209 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 20
Study 6103209 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 20
Study 30939188 — intervention group
Group type: EXPERIMENTAL
Intervention: Spring Pillow
Number of subjects: 70
Study 30939188 — intervention group
Group type: COMPARATOR
Intervention: Educational Intervention
Number of subjects: 70
Study 28662137 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity (average daily minutes = 24.0±18.3)
Number of subjects: 504
Study 28662137 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behaviour (average daily minutes = 535.2±83.8)
Number of subjects: 504
Study 28662137 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity frequency (average daily bouts ≥10 min = 0.64±0.74)
Number of subjects: 504
Study 28662137 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behaviour frequency
Number of subjects: 504
Study 25909356 — intervention group
Group type: EXPERIMENTAL
Intervention: Grazoprevir 100 mg/elbasvir 50 mg (oral, once-daily for 12 weeks)
Number of subjects: 421
Study 25909356 — intervention group
Group type: COMPARATOR
Intervention: Placebo (deferred therapy)
Number of subjects: 421
Study 25909356 — intervention group
Group type: EXPERIMENTAL
Intervention: Grazoprevir 100 mg/elbasvir 50 mg
Number of subjects: 421
Study 22814814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambrisentan therapy for 12 weeks
Number of subjects: 370
Study 20387085 — intervention group
Group type: EXPERIMENTAL
Intervention: Philips Sonicare Elite with medium brush head
Number of subjects: 90
Study 20387085 — intervention group
Group type: EXPERIMENTAL
Intervention: Philips Sonicare Elite with mini brush head
Number of subjects: 90
Study 20387085 — intervention group
Group type: EXPERIMENTAL
Intervention: American Dental Association (ADA) reference toothbrush
Number of subjects: 90
Study 20387085 — intervention group
Group type: EXPERIMENTAL
Intervention: Elmex Sensitive toothbrush
Number of subjects: 90
Study 20387085 — intervention group
Group type: COMPARATOR
Intervention: All toothbrushes
Number of subjects: 90
Study 19468264 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine replacement
Number of subjects: 23
Study 19468264 — intervention group
Group type: COMPARATOR
Intervention: Untreated group (control)
Number of subjects: 23
Study 17598652 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month cardiac rehabilitation program (45-minute training on cycle ergometer three times per week and generally improving exercises two times per week)
Number of subjects: 66
Study 17598652 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 66
Study 15036709 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 100 microg
Number of subjects: 72
Study 15036709 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol 50 microg
Number of subjects: 72
Study 11068197 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz) applied to the left dorsolateral prefrontal cortex for 5 days
Number of subjects: 12
Study 11068197 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study 11068197 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz)
Number of subjects: 12
Study 9432193 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablets containing Noveon AA1 (10% w/w)
Number of subjects: 0
Study 9432193 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablets containing Methocel K4M (10% w/w)
Number of subjects: 0
Study 9432193 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablets containing Carbopol 974P (10% w/w)
Number of subjects: 0
Study 1519779 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O (nitrous oxide) continued after dural closure
Number of subjects: 24
Study 1519779 — intervention group
Group type: COMPARATOR
Intervention: N2 (nitrogen) replaced N2O at dural closure
Number of subjects: 24
Study 6473753 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-instructional method
Number of subjects: 0
Study 6473753 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture instruction
Number of subjects: 0
Study 30966831 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 80
Study 30966831 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (Control)
Number of subjects: 80
Study 28540411 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐month Assertive Community Treatment (ACT) as part of integrated care
Number of subjects: 120
Study 28540411 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study 27751214 — intervention group
Group type: EXPERIMENTAL
Intervention: VR training
Number of subjects: 35